Effects of Electrochemotherapy with Cisplatin on Tumor Blood Flow and Oxygenation
Author Information
Author(s): Sersa G, Krzic M, Sentjurc M, Ivanusa T, Beravs K, Kotnik V, Coer A, Swartz H M, Cemazar M
Primary Institution: Institute of Oncology Ljubljana
Hypothesis
The study aims to determine the effects of electrochemotherapy with cisplatin on tumor blood flow and oxygenation and their relation to antitumor effectiveness.
Conclusion
Electrochemotherapy with cisplatin significantly reduces tumor blood flow and oxygenation, which correlates with increased tumor necrosis and apoptosis.
Supporting Evidence
- Electrochemotherapy induced a 9.4 days tumor growth delay.
- Reduced tumor blood flow persisted for several days after treatment.
- Maximal reduction in partial oxygen pressure was observed at 2 hours post-treatment.
Takeaway
This study shows that a special treatment called electrochemotherapy can help make cancer drugs work better by reducing blood flow to tumors, which helps kill more cancer cells.
Methodology
Electrochemotherapy was performed on SA-1 tumors using electric pulses after administering cisplatin, with tumor blood flow and oxygenation measured using various imaging techniques.
Potential Biases
Potential bias in the measurement of tumor responses due to subjective assessments in histological evaluations.
Limitations
The study primarily focuses on a single tumor model and may not be generalizable to all types of tumors.
Participant Demographics
A/J mice, 10-14 weeks old, both sexes.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website